Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
Clinical trial NCT05045248 · COMPLETED
Trial details
- NCT number
- NCT05045248
- Sponsor
- American University of Beirut Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2021-04-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.